Chairman and CEO

Chief Executive Officer (CEO)

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs

Beyond the Code: Morgan Stanley's Human-First Approach to AI Governance (Ft. Jeff McMillan on The RegulatingAI Podcast)

Why Dyne Therapeutics Stock Tanked on Tuesday

Anti-money Laundering Risk – Enhanced Due Diligence (AML Risk Assistant Vice President)

Morgan Stanley is a global financial services firm that provides comprehensive financial advice and services. The AML Risk Assistant Vice President will oversee due diligence and risk-relevant activities related to anti-money laundering, focusing on assessing and escalating potential money laundering and reputational risk issues associated with higher risk client types.

Sign up with Google

Sign in with Google